Precigen (PGEN) Receivables (2012 - 2026)
Precigen (PGEN) posted quarterly Receivables of $26.7 million for Q1 2026, up 2409.87% year-over-year from $1.1 million in Q1 2025, and up 595.08% quarter-over-quarter from $3.8 million in Q4 2025.
Precigen (PGEN) Receivables (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Receivables for 15 consecutive years, with $26.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables rose 2409.87% year-over-year to $26.7 million; the TTM figure through Mar 2026 stood at $26.7 million (up 2409.87% YoY), while the FY2025 annual figure was $4.4 million, up 793.85% from the prior year.
- Receivables improved to $26.7 million in Q1 2026 per PGEN's latest filing, from $3.8 million in the prior quarter.
- Across five years, Receivables topped out at $26.7 million in Q1 2026 and bottomed at -$11.5 million in Q4 2023.
- Historically, Receivables has averaged $6.4 million across 5 years, with a median of $1.3 million in 2022.
- Annual changes were most pronounced in 2023 — Receivables plunged 191.41% — and 2026, when it surged 2409.87%.
- Precigen's Receivables stood at $12.6 million in 2022, then sank by 191.41% to -$11.5 million in 2023, then jumped by 107.98% to $919000.0 in 2024, then surged by 318.06% to $3.8 million in 2025, then surged by 595.08% to $26.7 million in 2026.
- Business Quant data shows PGEN's Receivables at $26.7 million in Q1 2026, $3.8 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn | 72.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72.04 Mn |
| Mar 31, 2026 | 26.71 Mn |
| Dec 31, 2025 | 3.84 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 571,000.00 |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 919,000.00 |
| Sep 30, 2024 | 729,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 489,000.00 |
| Dec 31, 2023 | -11.52 Mn |
| Sep 30, 2023 | 14.11 Mn |
| Jun 30, 2023 | 14.41 Mn |
| Mar 31, 2023 | 15.52 Mn |
| Dec 31, 2022 | 12.60 Mn |
| Sep 30, 2022 | 2.44 Mn |
| Jun 30, 2022 | 1.33 Mn |
| Mar 31, 2022 | 24.29 Mn |
| Dec 31, 2021 | 1.62 Mn |
| Sep 30, 2021 | 20.24 Mn |